Open Innovation

Let’s bring great ideas to life

Share our passion for new paths in life sciences. Join us in Open Innovation.
OUR COMMITMENT

What's new in Open Innovation

Bayer becomes partner of the Centre for Crop Health and Protection consortium

November 10, 2016

Bayer has joined the Centre for Crop Health and Protection (CHAP) located at Sand Hutton, United Kingdom, which unites public academic institutions and private companies. The partners will collaborate on innovative solutions to improve agricultural productivity – a vital aspect of food security.

Stay tuned on Open Innovation

Keep updated with our latest news.

Innovation Stories

Innovation Stories

  • Bayer’s researchers have new ideas for developing active medications and clinician researchers like us can screen and select patients based on these ideas who may benefit.
    Prof. Boon Cher Goh, National University Cancer Institute of Singapore
    Read the full story
  • The ‘Grants4Apps Accelerator’ gives innovators a chance to learn and fine-tune everything it takes to successfully market their ideas.
    Jesus del Valle Rosales, Intrapreneurship & Innovation, Bayer Business Services
    Read the full story
  • A growing and aging world population, limited natural resources and the impact of climate change make it important to improve crop yield, stress tolerance and nutritional value while minimizing environmental impact.
    Arjen J. van Tunen, CEO KeyGene
    Read the full story
  • We thought we had a mature understanding of our business model – and emerged with a model that is actually viable for a startup company.
    Robert Green, co-founder Vitameter
    Read the full story
  • I expect immunoncology to become established as an integral part of cancer treatment over the next few years and to offer real prospects.
    Professor Rienk Offringa, Head of the Bayer-DKFZ Joint Lab
    Read the full story
  • Startups whose work is related to Bayer’s pharmaceutical R&D focus are offered rental office and lab space on the company’s campus in Berlin. Working side by side has inspired fruitful scientific discussion.
    Stefan Jaroch, Drug Discovery, Global External Innovation & Alliances, Bayer Pharmaceuticals division
    Read the full story

OPEN INNOVATION IN NUMBERS

Our scientific successes are intended to help improve people’s lives.
At the same time, our innovations form the basis for sustainable and profitable business activity.

0
IDEAS
0
COUNTRIES
0
PROJECTS FUNDED
0
EMPLOYEES
OPEN INNOVATION
IN NUMBERS
2,370 IDEAS
have been submitted to Bayer Open Innovation programs since 2009.
60 COUNTRIES
innovative solutions have been submitted from more than 60 countries worldwide.
220 PROJECTS FUNDED
more than 220 ideas have been supported through Open Innovation Grants from Bayer.
14,026 EMPLOYEES
over 14,000 Bayer employees currently work in R&D.
OPEN INNOVATION
IN NUMBERS
2,370 IDEAS
have been submitted to Bayer Open Innovation programs since 2009.
60 COUNTRIES
innovative solutions have been submitted from more than 60 countries worldwide.
220 PROJECTS FUNDED
more than 220 ideas have been supported through Open Innovation Grants from Bayer.
14,026 EMPLOYEES
over 14,000 Bayer employees currently work in R&D.